Rheumatoid, Gout Flashcards
Class;Mechanism;Therapeutics;SideEffects
Indomethacin (Indocin)
Non-selective NSAID Eliminate pain; reduce inflammation (but does not slow disease progression) Rheumatoid arthritis; acute gouty arthritis Gastric and duodenal ulcers — —
Class;Mechanism;Therapeutics;SideEffects
Naproxen (Aleve)
Non-selective NSAID Eliminate pain; reduce inflammation (but does not slow disease progression) Rheumatoid arthritis; acute gouty arthritis Gastric and duodenal ulcers — —
Class;Mechanism;Therapeutics;SideEffects
COX-2 inhibitors
Selective NSAID Eliminate pain; reduce inflammation (but does not slow disease progression) Superseding conventional NSAIDs for rheumatoid arthritis 50% fewer gastric and duodenal ulcers than traditional NSAIDs — —
Class;Mechanism;Therapeutics;SideEffects
Gold Salts
DMARD Antipruritic; represses immune responsiveness (inhibits functional capabilities of macrophages) Rheumatoid arthritis Serious side effects in 30% of pts — Rarely used today
Class;Mechanism;Therapeutics;SideEffects
Quinolones
DMARD (antimalarial) Reduces T-cell activation & chemotaxis Rheumatoid arthritis, SLE Retinal damage (chloroquine) — Used for patients who no longer respond to NSAIDS or can’t tolerate gold or penillamine
Class;Mechanism;Therapeutics;SideEffects
Glucocorticoids
(Corticosteroids)
DMARD 1. Inhibits phospholipase A2 (inhibiting release of arachidonic acid and, thus, formation of prostaglandins)
2. Inhibits cytokine production (which prevents induction of COX-2) Rheumatoid arthritis; acute gouty arthritis (intraarticular injection for relief of acute monoarticular gout) Cushingoid symptoms — Started initially (fast acting) before other drugs become effective
Can give orally or intra-articularly
Class;Mechanism;Therapeutics;SideEffects
Sulfasalazine (Azulfidine)
DMARD Likely inhibition of IL-1 & TNF-alpha release Rheumatoid arthritis N/V, skin rashes, neutropenia (30% of patient discontinue drug) Headaches Acts more quickly than other drugs
Class;Mechanism;Therapeutics;SideEffects
Methotrexate (Trexall)
DMARD
(Immunosuppressive) 1. Inhibition of aminoimidazolecarboxamide (AICAR) transformylase and
thymidylate synthetase, with secondary effects on PMN chemotaxis
2. Causes adenosine accumulation, which inhibits inflammation Rheumatoid arthritis Nausea, stomatitis, hepatotoxicity (rare) — Takes several weeks to start working; “gold standard” of therapy
Class;Mechanism;Therapeutics;SideEffects
Leflunomide (Arava)
DMARD
(Immunosuppressive) Inhibits dihydroorotate dehydrogenase (DHODH), which inhibits T-lymphocyte response to stimuli Rheumatoid arthritis Diarrhea, hepatotoxity — Takes several weeks to start working; oral prodrug
Class;Mechanism;Therapeutics;SideEffects
Etanercept (Enbrel)
Biologic Response Modifiers Blocks binding of TNF to TNF receptors Rheumatoid arthritis — — Twice weekly subcutaneous injections
Class;Mechanism;Therapeutics;SideEffects
Infliximab (Remicade)
Biologic Response Modifiers Blocks binding of TNF to TNF receptors Rheumatoid arthritis Antigenic response to murine monoclonal Ab — —
Class;Mechanism;Therapeutics;SideEffects
Adalimumab (Humira)
Biologic Response Modifiers Blocks binding of TNF to TNF receptors Rheumatoid arthritis — — Fully human, so no antigenic response; twice monthly injections
Class;Mechanism;Therapeutics;SideEffects
Golimumab
Biologic Response Modifiers Blocks binding of TNF to TNF receptors Rheumatoid arthritis Risk of serious infections
Class;Mechanism;Therapeutics;SideEffects
Certolizumab
Biologic Response Modifiers Blocks binding of TNF to TNF receptors Rheumatoid arthritis Risk of serious infections Conjugated to PEG for stabilization
Class;Mechanism;Therapeutics;SideEffects
Anakinra (Kineret)
Biologic Response Modifiers IL-1 Receptor Antagonist Rheumatoid arthritis — — Short (6 hr) plasma half-life; daily treatment with high doses